PresentationGood morning, everyone. My name is Will Pickering. I cover U.S. biotech at Bernstein. Very pleased today to have Regeneron Pharmaceuticals with us. I'm joined by CFO, Chris Fenimore; and SVP and Head of Investor Relations, Ryan Crowe. Thanks so much. And Ryan, let me hand it over to you for some forward-looking statements.Ryan CroweSenior Vice President of Investor Relations & Strategic Analysis Thanks, Will, for having us at the Bernstein Conference. Always great to be here and Sanitova to all ...